No problem. I asked twice last week if someone could give me any Big catalyst that were coming to make this one worth a buy and nobody had anything worth wild. This is a case of them way overspending a drug that just has no traction what so ever. I mean when I read that it did 30 million in 3 years that cracked me up. That is very weak sales. I wish people luck that are in it.
News 
Market Data 
Discover 
